Altogether, our observations suggest a role of the three new rare TMPO variants identified in cardiomyopathy patients in altering the properties of LAP2 proteins, and subsequent dysfunction of partners playing a role in chromatin compaction and/or gene expression. Here, TMPO is linked to cardiomyopathy.